Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Dulaglutides efficacy: in the AWARD trial program, weekly dulaglutide 1.5 mg was shown to reduce HbAc by ~1.0% to 1.5% (baseline ~8.1%) and was superior to placebo and non-inferior or superior to comparators like insulin glargine or Byetta in certain studies ( [6] )
But the signal is spreading
It is believed to be a result of the drugs effects on gut motility and digestion
While they share a common mechanism of action, enhancing glucose-dependent insulin secretion, reducing glucagon secretion, and slowing gastric emptying, there are notable differences in their efficacy and usage in weight management
"It can make it even harder to try and stick to healthy eating and avoiding those foods that we know aren't good for us." But the new GLP-1 injectable drugs can turn down the volume, allowing those battling obesity to change their relationship with food
